Ch protein including gene entities (eg

Матеріал з HistoryPedia
Перейти до: навігація, пошук

DEPs in every of your experimental groups (OS/OB, metastasis, and chemoresistance) have been on top of that categorized around the basis of their biological processes applying GO10 and had been designated as GO termsTechniques 2De, MalDi-TOF 2De, MalDi-TOF 2D-Dige, lc-esi-Ms/Ms 2De, MalDi-TOF iTraQ labeling, lc-Ms/Ms 2De, esi-Ms/Ms 1De, lc-Ms/Ms, label-free quantitative protein evaluation 2De, TOF/TOFYear 2006 2007 2009 2009 2010 2011 2013Citation Spreafico et al15 guo et al16 Folio et al17 liu et al18 Zhang et al19 hua et al22 PosthumaDeboer et al20 gemoll et alAbbreviations: OS, osteosarcoma; OB, osteoblastic; 2DE, two-dimensional gel electrophoresis; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; 2D-Dige, two-dimensional distinction gel electrophoresis; iTraQ, isobaric tags for relative and absolute quantitation; lc-Ms/Ms, liquid chromatographytandem mass spectrometry; ESI-MS/MS, electrospray ionization mass spectrometry; TOF/TOF, tandem time-of-flight.OncoTargets and Therapy 2017:submit your manuscript | www.dovepress.comDovepresschaiyawat et alDovepressTable 3 Proteomics research of metastasis in OsModel Non-metastasis Os cell lines: hOs, saOs-2 low-metastatic subline: F4 Os , {due to|because of|as a result of|on account of tissue devoid of metastasis OB cell line: hFOB1.19 Metastasis Os metastatic sublines: 143B, lM7 highly metastatic subline: F5M2 Os tissue with metastasized to lung Os cell lines: hs 39.T, hs 184.T, and hs 188.T a lectin column followed by MudPiT 2D-Dige, MalDi-TOF 2De, MalDi-TOF 2De, TOF/TOF 2012 2014 2014 2015 Flores et al54 chen et al55 Tang et al56 gemoll et al21 Approaches Year CitationAbbreviations: OS, osteosarcoma; MudPIT, multidimensional protein identification technologies; 2D-DIGE, two-dimensional distinction gel electrophoresis; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; 2DE, two-dimensional gel electrophoresis; TOF/TOF, tandem time-of-flight.(Figure 1). DEPs in each from the experimental groups (OS/OB, metastasis, and chemoresistance) have been also categorized around the basis of their biological processes employing GO10 and were designated as GO termsTechniques 2De, MalDi-TOF 2De, MalDi-TOF 2D-Dige, lc-esi-Ms/Ms 2De, MalDi-TOF iTraQ labeling, lc-Ms/Ms 2De, esi-Ms/Ms 1De, lc-Ms/Ms, label-free quantitative protein evaluation 2De, TOF/TOFYear 2006 2007 2009 2009 2010 2011 2013Citation Spreafico et al15 guo et al16 Folio et al17 liu et al18 Zhang et al19 hua et al22 PosthumaDeboer et al20 gemoll et alAbbreviations: OS, osteosarcoma; OB, osteoblastic; 2DE, two-dimensional gel electrophoresis; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; 2D-Dige, two-dimensional difference gel electrophoresis; iTraQ, isobaric tags for relative and absolute quantitation; lc-Ms/Ms, liquid chromatographytandem mass spectrometry; ESI-MS/MS, electrospray ionization mass spectrometry; TOF/TOF, tandem time-of-flight.OncoTargets and Therapy 2017:submit your manuscript | www.dovepress.comDovepresschaiyawat et alDovepressTable 3 Proteomics studies of metastasis in OsModel Non-metastasis Os cell lines: hOs, saOs-2 low-metastatic subline: F4 Os tissue without metastasis OB cell line: hFOB1.19 Metastasis Os metastatic sublines: 143B, lM7 very metastatic subline: F5M2 Os tissue with metastasized to lung Os cell lines: hs 39.T, hs 184.T, and hs 188.T a lectin column followed by MudPiT 2D-Dige, MalDi-TOF 2De, MalDi-TOF 2De, TOF/TOF 2012 2014 2014 2015 Flores et al54 chen et al55 Tang et al56 gemoll et al21 Techniques Year CitationAbbreviations: OS, osteosarcoma; MudPIT, multidimensional protein identification technologies; 2D-DIGE, two-dimensional difference gel electrophoresis; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; 2DE, two-dimensional gel electrophoresis; TOF/TOF, tandem time-of-flight.(Figure 1). It was discovered that more than half the DEPs in all of the experimental groups were involved in metabolic and cellular processes. Lower pathway enrichment involved developmental processes, localization, biological regulation, and so on. The diversity of those pathways varied slightly among the experimental groups. The complete list of biological processes is offered inside the Supplementary materials.